Elisa Melucci

1.2k total citations
31 papers, 871 citations indexed

About

Elisa Melucci is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Elisa Melucci has authored 31 papers receiving a total of 871 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Oncology, 12 papers in Molecular Biology and 11 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Elisa Melucci's work include HER2/EGFR in Cancer Research (10 papers), Colorectal Cancer Treatments and Studies (8 papers) and Cancer Genomics and Diagnostics (6 papers). Elisa Melucci is often cited by papers focused on HER2/EGFR in Cancer Research (10 papers), Colorectal Cancer Treatments and Studies (8 papers) and Cancer Genomics and Diagnostics (6 papers). Elisa Melucci collaborates with scholars based in Italy, Malaysia and United States. Elisa Melucci's co-authors include Marcella Mottolese, Isabella Sperduti, Pier Giorgio Natali, Alessandra Fabi, Letizia Perracchio, Irene Terrenato, Patrizio Giacomini, Cecilia Nisticò, Anna Di Benedetto and Giovanni Blandino and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Immunology and PLoS ONE.

In The Last Decade

Elisa Melucci

28 papers receiving 852 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elisa Melucci Italy 18 465 421 244 144 108 31 871
Hyung‐Gyoon Kim United States 17 405 0.9× 541 1.3× 189 0.8× 197 1.4× 134 1.2× 33 1.0k
Yves Hüsemann Germany 4 716 1.5× 415 1.0× 415 1.7× 147 1.0× 146 1.4× 4 1.0k
Lizhou Jia China 19 433 0.9× 468 1.1× 265 1.1× 224 1.6× 123 1.1× 45 968
François Kuonen Switzerland 17 287 0.6× 298 0.7× 148 0.6× 171 1.2× 80 0.7× 42 712
Vida Vafaizadeh Germany 17 409 0.9× 675 1.6× 334 1.4× 148 1.0× 67 0.6× 25 1.1k
Melissa C Adriance United States 7 380 0.8× 472 1.1× 154 0.6× 150 1.0× 77 0.7× 7 805
Htoo Zarni Oo Canada 21 453 1.0× 743 1.8× 347 1.4× 121 0.8× 147 1.4× 54 1.2k
Massimiliano Cariati United Kingdom 10 453 1.0× 313 0.7× 194 0.8× 54 0.4× 90 0.8× 21 784
Nilay S. Sethi United States 14 592 1.3× 726 1.7× 312 1.3× 114 0.8× 202 1.9× 26 1.3k
Joseph L. Sottnik United States 17 341 0.7× 342 0.8× 163 0.7× 105 0.7× 264 2.4× 26 837

Countries citing papers authored by Elisa Melucci

Since Specialization
Citations

This map shows the geographic impact of Elisa Melucci's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisa Melucci with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisa Melucci more than expected).

Fields of papers citing papers by Elisa Melucci

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elisa Melucci. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisa Melucci. The network helps show where Elisa Melucci may publish in the future.

Co-authorship network of co-authors of Elisa Melucci

This figure shows the co-authorship network connecting the top 25 collaborators of Elisa Melucci. A scholar is included among the top collaborators of Elisa Melucci based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elisa Melucci. Elisa Melucci is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Valentini, Elisabetta, Marta Di Martile, Simona D’Aguanno, et al.. (2026). PROTAC-mediated degradation of Bcl-xL potentiates target therapy in preclinical melanoma models. Journal of Experimental & Clinical Cancer Research. 45(1). 37–37.
2.
Baldassarre, Gustavo, Gabriella Cirmena, Dario de Biase, et al.. (2025). Liquid biopsy in prostate cancer: A multidisciplinary expert consensus statement. Tumori Journal. 111(6). 496–505.
3.
Eibenschutz, Laura, Silvia Caputo, Alberto Marini, et al.. (2025). Resistance to SMO Inhibitors in Advanced Basal Cell Carcinoma: A Case Highlighting the Role of Molecular Tumor Profiling. International Journal of Molecular Sciences. 27(1). 68–68.
4.
D’Antonio, Mattia, Elisa Melucci, Simonetta Buglioni, et al.. (2023). Development of a somatic variant registry in a National Cancer Center: towards Molecular Real World Data preparedness. Journal of Biomedical Informatics. 142. 104394–104394. 1 indexed citations
5.
D’Agata, Roberta, Noemi Bellassai, Matteo Allegretti, et al.. (2020). Direct plasmonic detection of circulating RAS mutated DNA in colorectal cancer patients. Biosensors and Bioelectronics. 170. 112648–112648. 29 indexed citations
6.
Donzelli, Sara, Andrea Sacconi, Silvia Masciarelli, et al.. (2018). Expression of ID4 protein in breast cancer cells induces reprogramming of tumour-associated macrophages. Breast Cancer Research. 20(1). 59–59. 40 indexed citations
7.
Gasparello, Jessica, Matteo Allegretti, Elisa Tremante, et al.. (2018). Liquid biopsy in mice bearing colorectal carcinoma xenografts: gateways regulating the levels of circulating tumor DNA (ctDNA) and miRNA (ctmiRNA). Journal of Experimental & Clinical Cancer Research. 37(1). 124–124. 27 indexed citations
8.
Garufi, Carlo, Elisa Giacomini, Angela Torsello, et al.. (2016). Gender effects of single nucleotide polymorphisms and miRNAs targeting clock-genes in metastatic colorectal cancer patients (mCRC). Scientific Reports. 6(1). 34006–34006. 17 indexed citations
9.
Paolini, Francesca, Elisa Melucci, Irene Terrenato, et al.. (2016). Human papillomavirus 16 E2 interacts with neuregulin receptor degradation protein 1 affecting ErbB-3 expression in vitro and in clinical samples of cervical lesions. European Journal of Cancer. 58. 52–61. 8 indexed citations
10.
Melucci, Elisa, Maurizio Cosimelli, L Carpanese, et al.. (2013). Decrease of survivin, p53 and Bcl-2 expression in chemorefractory colorectal liver metastases may be predictive of radiosensivity after radioembolization with yttrium-90 resin microspheres. Journal of Experimental & Clinical Cancer Research. 32(1). 13–13. 12 indexed citations
11.
Lattanzio, Rossano, Marco Marchisio, Rossana La Sorda, et al.. (2012). Overexpression of activated phospholipase Cγ1 is a risk factor for distant metastases in T1‐T2, N0 breast cancer patients undergoing adjuvant chemotherapy. International Journal of Cancer. 132(5). 1022–1031. 35 indexed citations
12.
Fabi, Alessandra, Anna Di Benedetto, Giulio Metro, et al.. (2011). HER2 Protein and Gene Variation between Primary and Metastatic Breast Cancer: Significance and Impact on Patient Care. Clinical Cancer Research. 17(7). 2055–2064. 72 indexed citations
13.
Monaco, Elisa Lo, Elisa Tremante, Cristina Cerboni, et al.. (2011). Human Leukocyte Antigen E Contributes to Protect Tumor Cells from Lysis by Natural Killer Cells. Neoplasia. 13(9). 822–IN14. 71 indexed citations
14.
Modugno, Francesca Di, Marcella Mottolese, Lucia De Monte, et al.. (2010). The Cooperation between hMena Overexpression and HER2 Signalling in Breast Cancer. PLoS ONE. 5(12). e15852–e15852. 21 indexed citations
15.
Mottolese, Marcella, Flavia Novelli, Elisa Melucci, et al.. (2009). Identification of an Adverse Biologic Profile in Cyclophosphamide/Metotrexate/5-Fluorouracil Treated Early Stage Breast Cancer Patients by Immunohistochemical Analysis of PI3K/p-Akt Pathway Alterations.. Cancer Research. 69(24_Supplement). 6036–6036. 1 indexed citations
16.
Fontemaggi, Giulia, Stefania Dell’Orso, Daniela Trisciuoglio, et al.. (2009). The execution of the transcriptional axis mutant p53, E2F1 and ID4 promotes tumor neo-angiogenesis. Nature Structural & Molecular Biology. 16(10). 1086–1093. 167 indexed citations
17.
Monaco, Elisa Lo, Leonardo Sibilio, Elisa Melucci, et al.. (2008). HLA-E: Strong Association with β2-Microglobulin and Surface Expression in the Absence of HLA Class I Signal Sequence-Derived Peptides. The Journal of Immunology. 181(8). 5442–5450. 33 indexed citations
18.
Novelli, Flavia, Michele Stanislaw Milella, Elisa Melucci, et al.. (2008). A divergent role for estrogen receptor-beta in node-positive and node-negative breast cancer classified according to molecular subtypes: an observational prospective study. Breast Cancer Research. 10(5). R74–R74. 86 indexed citations
19.
Folgiero, Valentina, Giulia Bon, Selene E. Di Carlo, et al.. (2008). Induction of ErbB-3 Expression by α6β4 Integrin Contributes to Tamoxifen Resistance in ERβ1-Negative Breast Carcinomas. PLoS ONE. 3(2). e1592–e1592. 43 indexed citations
20.
Fabi, Alessandra, Giulio Metro, Paola Papaldo, et al.. (2007). Impact of celecoxib on capecitabine tolerability and activity in pretreated metastatic breast cancer: results of a phase II study with biomarker evaluation. Cancer Chemotherapy and Pharmacology. 62(4). 717–725. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026